Zobrazeno 1 - 10
of 253
pro vyhledávání: '"Ortuzar, N."'
Autor:
Ortuzar, N., Karu, K., Presa, Daniela, Morais, Goreti R., Sheldrake, Helen M., Shnyder, Steven, Barnieh, Francis M., Loadman, Paul, Patterson, Laurence H., Pors, Klaus, Searcey, M.
Yes
The duocarmycins belong to a class of agent which has great potential for use in cancer therapy. Their exquisite potency means they are too toxic for systemic use, and targeted approaches are required to unlock their clinical potential. In t
The duocarmycins belong to a class of agent which has great potential for use in cancer therapy. Their exquisite potency means they are too toxic for systemic use, and targeted approaches are required to unlock their clinical potential. In t
Externí odkaz:
http://hdl.handle.net/10454/18559
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vaquero-Rodríguez A; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., Ortuzar N; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., Lafuente JV; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., Bengoetxea H; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
Publikováno v:
Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] 2023 Apr; Vol. 248 (7), pp. 553-560. Date of Electronic Publication: 2023 Jun 13.
Autor:
Vaquero-Rodríguez A; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain., Razquin J; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain., Zubelzu M; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain., Bidgood R; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain., Bengoetxea H; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain., Miguelez C; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain., Morera-Herreras T; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain; Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain., Ruiz-Ortega JA; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain; Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria, Spain., Lafuente JV; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain., Ortuzar N; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain; Neurodegenerative diseases Group, Biocruces Health Research Institute, Barakaldo, Bizkaia, Spain. Electronic address: naiara.ortuzar@ehu.eus.
Publikováno v:
International review of neurobiology [Int Rev Neurobiol] 2023; Vol. 172, pp. 103-143. Date of Electronic Publication: 2023 Jun 08.
Autor:
Stephens M; Vicomtech Foundation, Donostia-San Sebastián, Spain., López-Linares K; Vicomtech Foundation, Donostia-San Sebastián, Spain.; Grupo de E-Salud del Área de Bioingeniería, Biodonostia, Donostia-San Sebastián, Spain., Aldazabal J; TECNUN - Universidad de Navarra, Manuel de Lardizábal 13, 20018, Donostia-San Sebastián, Spain., Macias I; Stem Cells and Cell Therapy Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S/N, 48903, Barakaldo, Bizkaia, Spain., Ortuzar N; University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain., Bengoetxea H; University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain., Bulnes S; University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain., Alcorta-Sevillano N; Stem Cells and Cell Therapy Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S/N, 48903, Barakaldo, Bizkaia, Spain.; University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain., Infante A; Stem Cells and Cell Therapy Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S/N, 48903, Barakaldo, Bizkaia, Spain., Lafuente JV; Laboratory of Clinical and Experimental Neuroscience, Department of Neuroscience, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain., Rodríguez CI; Stem Cells and Cell Therapy Laboratory, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S/N, 48903, Barakaldo, Bizkaia, Spain. cirodriguez@osakidetza.eus.
Publikováno v:
Scientific data [Sci Data] 2021 Sep 15; Vol. 8 (1), pp. 240. Date of Electronic Publication: 2021 Sep 15.
Autor:
Ortuzar N; Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK., Karu K; Department of Pharmaceutical and Biological Chemistry, UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK., Presa D; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, BD7 1DP, UK., Morais GR; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, BD7 1DP, UK., Sheldrake HM; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, BD7 1DP, UK., Shnyder SD; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, BD7 1DP, UK., Barnieh FM; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, BD7 1DP, UK., Loadman PM; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, BD7 1DP, UK., Patterson LH; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, BD7 1DP, UK., Pors K; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, BD7 1DP, UK. Electronic address: k.pors1@bradford.ac.uk., Searcey M; School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: M.Searcey@uea.ac.uk.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2021 Jun 15; Vol. 40, pp. 116167. Date of Electronic Publication: 2021 Apr 21.
Autor:
Murueta-Goyena A; Laboratory of Clinical and Experimental Neuroscience, Department of Neuroscience, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain. ane.muruetagoyena@ehu.eus.; Neurodegenerative Diseases group, BioCruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo, Bizkaia, Spain. ane.muruetagoyena@ehu.eus., Ortuzar N; Laboratory of Clinical and Experimental Neuroscience, Department of Neuroscience, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain., Lafuente JV; Laboratory of Clinical and Experimental Neuroscience, Department of Neuroscience, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain.; Nanoneurosurgery Group, BioCruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo, Bizkaia, Spain., Bengoetxea H; Laboratory of Clinical and Experimental Neuroscience, Department of Neuroscience, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain.
Publikováno v:
Molecular neurobiology [Mol Neurobiol] 2020 Jan; Vol. 57 (1), pp. 125-134. Date of Electronic Publication: 2019 Sep 10.
Autor:
Murueta-Goyena A; LaNCE, Department of Neuroscience, University of the Basque Country (UPV/EHU), Barrio Sarriena, 48940, Leioa, Bizkaia, Spain. ane.muruetagoyena@ehu.eus., Ortuzar N; LaNCE, Department of Neuroscience, University of the Basque Country (UPV/EHU), Barrio Sarriena, 48940, Leioa, Bizkaia, Spain., Gargiulo PÁ; Laboratory of Neurosciences and Experimental Psychology, Area of Pharmacology, Department of Pathology, Faculty of Medical Sciences, National Council of Scientific and Technical Research, National University of Cuyo, Mendoza, Argentina., Lafuente JV; LaNCE, Department of Neuroscience, University of the Basque Country (UPV/EHU), Barrio Sarriena, 48940, Leioa, Bizkaia, Spain.; Nanoneurosurgery Group, BioCruces Health Research Institute, 48903, Barakaldo, Bizkaia, Spain.; Faculty of Health Science, Universidad Autónoma de Chile, Santiago de Chile, Chile., Bengoetxea H; LaNCE, Department of Neuroscience, University of the Basque Country (UPV/EHU), Barrio Sarriena, 48940, Leioa, Bizkaia, Spain.
Publikováno v:
Molecular neurobiology [Mol Neurobiol] 2018 Jan; Vol. 55 (1), pp. 42.
Autor:
Bengoetxea H; Laboratory of Clinical and Experimental Neuroscience (LaNCE), Department of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain. harkaitz.bengoetxea@ehu.eus., Rico-Barrio I; Department of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), Barrio Sarriena, E-48940, Leioa, Bizkaia, Spain., Ortuzar N; Laboratory of Clinical and Experimental Neuroscience (LaNCE), Department of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain., Murueta-Goyena A; Laboratory of Clinical and Experimental Neuroscience (LaNCE), Department of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain., Lafuente JV; Laboratory of Clinical and Experimental Neuroscience (LaNCE), Department of Neuroscience, Faculty of Medicine and Surgery, University of the Basque Country (UPV/EHU), 48940, Leioa, Bizkaia, Spain.; Nanoneurosurgery Group, BioCruces Health Research Institute, Barakaldo, Bizkaia, Spain.; Faculty of Health Science, Universidad Autónoma de Chile, Santiago de Chile, Chile.
Publikováno v:
Molecular neurobiology [Mol Neurobiol] 2018 Jan; Vol. 55 (1), pp. 43-59.
Autor:
Murueta-Goyena A; LaNCE, Department of Neuroscience, University of the Basque Country (UPV/EHU), Barrio Sarriena, E-48940, Leioa, Bizkaia, Spain. ane.muruetagoyena@ehu.eus., Ortuzar N; LaNCE, Department of Neuroscience, University of the Basque Country (UPV/EHU), Barrio Sarriena, E-48940, Leioa, Bizkaia, Spain., Gargiulo PÁ; Laboratory of Neurosciences and Experimental Psychology, Area of Pharmacology, Department of Pathology, Faculty of Medical Sciences, National University of Cuyo, National Council of Scientific and Technical Research, Mendoza, Argentina., Lafuente JV; LaNCE, Department of Neuroscience, University of the Basque Country (UPV/EHU), Barrio Sarriena, E-48940, Leioa, Bizkaia, Spain.; Nanoneurosurgery Group, BioCruces Health Research Institute, 48903, Barakaldo, Bizkaia, Spain.; Faculty of Health Science, Universidad Autónoma de Chile, Santiago de Chile, Chile., Bengoetxea H; LaNCE, Department of Neuroscience, University of the Basque Country (UPV/EHU), Barrio Sarriena, E-48940, Leioa, Bizkaia, Spain.
Publikováno v:
Molecular neurobiology [Mol Neurobiol] 2018 Jan; Vol. 55 (1), pp. 26-41.